Growth Metrics

Genmab A (GMAB) Non-Current Assets: 2018-2020

Historic Non-Current Assets for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to $250.6 million.

  • Genmab A's Non-Current Assets rose 4.76% to $212.00 in Q2 2023 from the same period last year, while for Jun 2023 it was $212.00, marking a year-over-year increase of 4.76%. This contributed to the annual value of $250.6 million for FY2020, which is 79.55% up from last year.
  • Latest data reveals that Genmab A reported Non-Current Assets of $250.6 million as of FY2020, which was up 79.55% from $139.6 million recorded in FY2019.
  • In the past 5 years, Genmab A's Non-Current Assets ranged from a high of $250.6 million in FY2020 and a low of $113.7 million during FY2018.
  • In the last 3 years, Genmab A's Non-Current Assets had a median value of $139.6 million in 2019 and averaged $167.9 million.
  • Data for Genmab A's Non-Current Assets shows a peak YoY skyrocketed of 79.55% (in 2020) over the last 5 years.
  • Genmab A's Non-Current Assets (Yearly) stood at $113.7 million in 2018, then increased by 22.79% to $139.6 million in 2019, then surged by 79.55% to $250.6 million in 2020.